Business ❯ Pharmaceutical Industry ❯ Market Trends
Eli Lilly Investor Reactions Investor Concerns Amgen AstraZeneca Investment GSK
Phase III results showed meaningful symptom gains, near-elimination of surgery, major reductions in steroid use.
